Richa Poddar
Chief Commercial Officer, Agios Pharmaceuticals.
Companies
- Agios PharmaceuticalsChief Commercial Officer Dec 15, 2021 to Oct 18, 20221
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Agios Pharmaceuticals AGIO8,508 shares2$292.3K at $34.36Oct 17, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Oct 17, 2022Shares withheld for tax 1,485 shares at $27.48 of Agios Pharmaceuticals2
- Oct 15, 2022Exercised options 5,000 shares of Agios Pharmaceuticals2
- Feb 22, 2022Shares withheld for tax 742 shares at $29.08 of Agios Pharmaceuticals3
- Feb 22, 2022Exercised options 658 shares of Agios Pharmaceuticals3
- Feb 18, 2022Exercised options 1,884 shares of Agios Pharmaceuticals3
- Feb 14, 2022Shares withheld for tax 590 shares at $30.50 of Agios Pharmaceuticals4
- Feb 14, 2022Exercised options 1,738 shares of Agios Pharmaceuticals4
- Feb 10, 2022Shares withheld for tax 725 shares at $31.43 of Agios Pharmaceuticals5
- Feb 10, 2022Exercised options 2,068 shares of Agios Pharmaceuticals5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Feb 23, 2022
- 4SEC EDGARForm 4 filed Feb 16, 2022
- 5SEC EDGARForm 4 filed Feb 14, 2022